AVEO Oncology
AVEO
#7148
Rank
C$0.71 B
Marketcap
C$20.51
Share price
0.00%
Change (1 day)
160.52%
Change (1 year)

AVEO Oncology (AVEO) - Total debt

Total debt on the balance sheet as of September 2022 : C$52.89 Million

According to AVEO Oncology 's latest financial reports the company's total debt is C$52.89 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)

Total debt by year

Year Total debt Change
2021-12-31C$48.39 M162.16%
2020-12-31C$18.45 M-10.35%
2019-12-31C$20.59 M-20.58%
2018-12-31C$25.92 M11.61%
2017-12-31C$23.23 M23.45%
2016-12-31C$18.81 M43.23%
2015-12-31C$13.13 M-45.18%
2014-12-31C$23.96 M17.23%
2013-12-31C$20.44 M-21.04%
2012-12-31C$25.89 M5.31%
2011-12-31C$24.58 M5.1%
2010-12-31C$23.39 M12.6%
2009-12-31C$20.77 M-18.85%
2008-12-31C$25.6 M70.2%
2007-12-31C$15.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
C$58.11 B 109,783.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$74.64 B 141,024.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$8.99 B 16,904.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$3.70 B 6,895.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$64.45 B 121,769.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$22.69 M-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA